Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians
- PMID: 23208168
- DOI: 10.7326/0003-4819-157-11-201212040-00008
Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians
Abstract
Background: Upper endoscopy is commonly used in the diagnosis and management of gastroesophageal reflux disease (GERD). Evidence demonstrates that it is indicated only in certain situations, and inappropriate use generates unnecessary costs and exposes patients to harms without improving outcomes.
Methods: The Clinical Guidelines Committee of the American College of Physicians reviewed evidence regarding the indications for, and yield of, upper endoscopy in the setting of GERD, and to highlight how clinicians can increase the delivery of high-value health care. BEST PRACTICE ADVICE 1: Upper endoscopy is indicated in men and women with heartburn and alarm symptoms (dysphagia, bleeding, anemia, weight loss, and recurrent vomiting). BEST PRACTICE ADVICE 2: Upper endoscopy is indicated in men and women with: Typical GERD symptoms that persist despite a therapeutic trial of 4 to 8 weeks of twice-daily proton-pump inhibitor therapy. Severe erosive esophagitis after a 2-month course of proton-pump inhibitor therapy to assess healing and rule out Barrett esophagus. Recurrent endoscopy after this follow-up examination is not indicated in the absence of Barrett esophagus. History of esophageal stricture who have recurrent symptoms of dysphagia. BEST PRACTICE ADVICE 3: Upper endoscopy may be indicated: In men older than 50 years with chronic GERD symptoms (symptoms for more than 5 years) and additional risk factors (nocturnal reflux symptoms, hiatal hernia, elevated body mass index, tobacco use, and intra-abdominal distribution of fat) to detect esophageal adenocarcinoma and Barrett esophagus. For surveillance evaluation in men and women with a history of Barrett esophagus. In men and women with Barrett esophagus and no dysplasia, surveillance examinations should occur at intervals no more frequently than 3 to 5 years. More frequent intervals are indicated in patients with Barrett esophagus and dysplasia.
Comment in
-
Upper endoscopy for gastroesophageal reflux disease.Ann Intern Med. 2013 Mar 19;158(6):502-3. doi: 10.7326/0003-4819-158-6-201303190-00022. Ann Intern Med. 2013. PMID: 23552463 No abstract available.
-
Author reply: To PMID 23208168.Ann Intern Med. 2013 Mar 19;158(6):503-4. doi: 10.7326/0003-4819-158-6-201303190-00023. Ann Intern Med. 2013. PMID: 23552485 No abstract available.
Summary for patients in
-
Summaries for patients. Upper endoscopy for gastroesophageal reflux disease.Ann Intern Med. 2012 Dec 4;157(11):I-28. doi: 10.7326/0003-4819-157-11-201212040-00001. Ann Intern Med. 2012. PMID: 23208179 No abstract available.
Similar articles
-
Summaries for patients. Upper endoscopy for gastroesophageal reflux disease.Ann Intern Med. 2012 Dec 4;157(11):I-28. doi: 10.7326/0003-4819-157-11-201212040-00001. Ann Intern Med. 2012. PMID: 23208179 No abstract available.
-
The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.Am J Gastroenterol. 2002 Oct;97(10):2524-9. doi: 10.1111/j.1572-0241.2002.06034.x. Am J Gastroenterol. 2002. PMID: 12385433
-
Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.Dis Esophagus. 2013 Jul;26(5):443-50. doi: 10.1111/j.1442-2050.2012.01381.x. Epub 2012 Aug 2. Dis Esophagus. 2013. PMID: 22862422
-
The Role of Esophagogastroduodenoscopy Surveillance for Patients with Barrett Esophagus.Med Clin North Am. 2016 Sep;100(5):1057-64. doi: 10.1016/j.mcna.2016.04.014. Med Clin North Am. 2016. PMID: 27542425 Review.
-
AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.Clin Gastroenterol Hepatol. 2022 May;20(5):984-994.e1. doi: 10.1016/j.cgh.2022.01.025. Epub 2022 Feb 2. Clin Gastroenterol Hepatol. 2022. PMID: 35123084 Free PMC article. Review.
Cited by
-
Hepatic hyperechoic lesion in a young, healthy man.Proc (Bayl Univ Med Cent). 2024 Jul 29;37(6):990-992. doi: 10.1080/08998280.2024.2379152. eCollection 2024. Proc (Bayl Univ Med Cent). 2024. PMID: 39440075 Free PMC article.
-
Improving esophageal cancer screening across the globe: Translating knowledge into action.Indian J Gastroenterol. 2024 Aug;43(4):705-716. doi: 10.1007/s12664-024-01543-z. Epub 2024 Jun 7. Indian J Gastroenterol. 2024. PMID: 38848004 Free PMC article. Review.
-
Advances in Screening for Barrett Esophagus and Esophageal Adenocarcinoma.Mayo Clin Proc. 2024 Mar;99(3):459-473. doi: 10.1016/j.mayocp.2023.07.014. Epub 2024 Jan 25. Mayo Clin Proc. 2024. PMID: 38276943 Review.
-
New Techniques to Screen for Barrett Esophagus.Gastroenterol Hepatol (N Y). 2023 Jul;19(7):383-390. Gastroenterol Hepatol (N Y). 2023. PMID: 37771620 Free PMC article.
-
Prevalence and Predictors of Barrett's Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases.Clin Gastroenterol Hepatol. 2024 Mar;22(3):523-531.e3. doi: 10.1016/j.cgh.2023.08.035. Epub 2023 Sep 15. Clin Gastroenterol Hepatol. 2024. PMID: 37716614
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical